This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: **Innovator Spotlight: Tianmin Niu**
Introduction
Tianmin Niu is a notable inventor based in Edmonton, Canada. With a keen focus on pharmaceuticals, he has made significant contributions to the field of cancer research through his innovative work.
Latest Patents
Tianmin holds a patent for a "Process for preparing a Cot inhibitor compound." This patent details the synthesis of a Cot inhibitor, which has shown promise in targeting cancer, specifically in the context of Osaka thyroid cancers. His pioneering work in this area adds valuable knowledge to cancer therapeutic strategies.
Career Highlights
Currently, Tianmin is employed by Gilead Sciences, Inc., a leading biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines in areas of unmet medical needs. His dedication to improving cancer treatment outlines how he utilizes his expertise to benefit the medical community.
Collaborations
During his career, Tianmin has collaborated with esteemed colleagues including Kevin M Allan and Lina Chan. Working together, they enhance the research environment and push the boundaries of innovation in the pharmaceutical industry.
Conclusion
Tianmin Niu's contributions to cancer research exemplify the impact that innovative ideas can have in the realm of medicine. His work continues to inspire others in the field and underscores the importance of persistent research and development for the advancement of healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile